Bally's Corp Discloses Executive Pay-for-Performance Amidst Significant Losses and Negative Shareholder Returns
Summary
Bally's Corp filed a supplement to its definitive proxy statement, adding the 'Pay Versus Performance' section which reveals substantial executive compensation for 2025 despite significant net losses and negative total shareholder returns.
Key Events
-
Executive Compensation Disclosed
The Principal Executive Officer (PEO) received $11,034,926 in compensation actually paid for 2025, with an average of $3,282,825 for non-PEO named executive officers.
-
Significant Net Losses Reported
The company reported substantial net losses of $(701,098,000) in 2025, following losses of $(567,754,000) in 2024 and $(187,500,000) in 2023.
-
Negative Shareholder Returns
Total Shareholder Return (TSR) for a $100 investment declined to $85.24 by the end of 2025, indicating negative returns for shareholders over the period.
-
Proxy Statement Supplement
This filing amends the definitive proxy statement from April 9, 2026, to include the previously omitted 'Pay Versus Performance' section, providing crucial data for shareholder review ahead of the annual meeting.
Analysis
This DEFA14A filing supplements Bally's Corp's definitive proxy statement from April 9, 2026, by adding the inadvertently omitted 'Pay Versus Performance' section. This disclosure is important as it reveals a significant disconnect between executive compensation and company performance. For 2025, the Principal Executive Officer (PEO) received over $11 million in compensation actually paid, while the company reported a net loss of over $700 million and experienced negative total shareholder returns. This information is critical for shareholders to assess the alignment of executive incentives with company and shareholder value creation, potentially influencing votes on compensation-related proposals at the upcoming annual meeting.
At the time of this filing, BALY was trading at $12.89 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $628.3M. The 52-week trading range was $8.46 to $20.74. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.